Literature DB >> 27180196

A first vascularized skin equivalent as an alternative to animal experimentation.

Florian Groeber1, Lisa Engelhardt2, Julia Lange3, Szymon Kurdyn2, Freia F Schmid1, Christoph Rücker2, Stephan Mielke3, Heike Walles1,2, Jan Hansmann1,2.   

Abstract

Tissue-engineered skin equivalents mimic key aspects of the human skin, and can thus be employed as wound coverage for large skin defects or as in vitro test systems as an alternative to animal models. However, current skin equivalents lack a functional vasculature limiting clinical and research applications. This study demonstrates the generation of a vascularized skin equivalent with a perfused vascular network by combining a biological vascularized scaffold (BioVaSc) based on a decellularized segment of a porcine jejunum and a tailored bioreactor system. Briefly, the BioVaSc was seeded with human fibroblasts, keratinocytes, and human microvascular endothelial cells. After 14 days at the air-liquid interface, hematoxylin & eosin and immunohistological staining revealed a specific histological architecture representative of the human dermis and epidermis including a papillary-like architecture at the dermal-epidermal-junction. The formation of the skin barrier was measured non-destructively using impedance spectroscopy. Additionally, endothelial cells lined the walls of the formed vessels that could be perfused with a physiological volume flow. Due to the presence of a complex in-vivo-like vasculature, the here shown skin equivalent has the potential for skin grafting and represents a sophisticated in vitro model for dermatological research.

Entities:  

Keywords:  alternative to animal testing; skin equivalents; tissue engineering ; vascularization

Mesh:

Year:  2016        PMID: 27180196     DOI: 10.14573/altex.1604041

Source DB:  PubMed          Journal:  ALTEX        ISSN: 1868-596X            Impact factor:   6.043


  35 in total

Review 1.  Biofabrication of thick vascularized neo-pedicle flaps for reconstructive surgery.

Authors:  Chelsea J Stephens; Jason A Spector; Jonathan T Butcher
Journal:  Transl Res       Date:  2019-05-21       Impact factor: 7.012

2.  Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model.

Authors:  Melva Suarez Muñoz; Davide Confalonieri; Heike Walles; Elisabeth M W M van Dongen; Gudrun Dandekar
Journal:  J Vis Exp       Date:  2018-02-07       Impact factor: 1.355

Review 3.  [Use of 2D and 3D cell cultures in dermatology].

Authors:  J Zeitvogel; T Werfel
Journal:  Hautarzt       Date:  2020-02       Impact factor: 0.751

4.  3D and 4D bioprinted human model patenting and the future of drug development.

Authors:  Fabio Mota; Luiza Braga; Leonardo Rocha; Bernardo Cabral
Journal:  Nat Biotechnol       Date:  2020-06       Impact factor: 54.908

Review 5.  Next generation human skin constructs as advanced tools for drug development.

Authors:  H E Abaci; Zongyou Guo; Yanne Doucet; Joanna Jacków; Angela Christiano
Journal:  Exp Biol Med (Maywood)       Date:  2017-06-07

6.  Recent Advances in Body-on-a-Chip Systems.

Authors:  Jong Hwan Sung; Ying I Wang; Narasimhan Narasimhan Sriram; Max Jackson; Christopher Long; James J Hickman; Michael L Shuler
Journal:  Anal Chem       Date:  2018-12-11       Impact factor: 6.986

7.  A biofabricated vascularized skin model of atopic dermatitis for preclinical studies.

Authors:  Xue Liu; Sam Michael; Kapil Bharti; Marc Ferrer; Min Jae Song
Journal:  Biofabrication       Date:  2020-04-09       Impact factor: 9.954

8.  ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models.

Authors:  Lars Wallstabe; Claudia Göttlich; Lena C Nelke; Johanna Kühnemundt; Thomas Schwarz; Thomas Nerreter; Hermann Einsele; Heike Walles; Gudrun Dandekar; Sarah L Nietzer; Michael Hudecek
Journal:  JCI Insight       Date:  2019-09-19

9.  Human barrier models for the in vitro assessment of drug delivery.

Authors:  Matthias Schweinlin; Angela Rossi; Nina Lodes; Christian Lotz; Stephan Hackenberg; Maria Steinke; Heike Walles; Florian Groeber
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

10.  Progress on Reconstructed Human Skin Models for Allergy Research and Identifying Contact Sensitizers.

Authors:  Charlotte Rodrigues Neves; Susan Gibbs
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.